title: Considerations on absence of 68Ga-DOTA-F(ab')2-trastuzumab tracer uptake in HER2-overexpressing tumor lesions.
authors.affiliation: aDepartment of Clinical Pharmacy, Medisch Spectrum Twente, Enschede Departments of bNuclear Medicine and Molecular Imaging cMedical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: Thijs H
authors.initials: TH
authors.lastname: Oude Munnink
authors.forename: Adrienne H
authors.initials: AH
authors.lastname: Brouwers
authors.forename: Elisabeth G E
authors.initials: EG
authors.lastname: de Vries
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000737:chemistry*; D001943:Breast Neoplasms / Q000175:diagnosis*; D005260:Female; D006573:Heterocyclic Compounds, 1-Ring / Q000737:chemistry*; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D006573:Heterocyclic Compounds, 1-Ring